DeuteRx is a research and development-focused biotechnology company dedicated to improving racemic small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications. The company specializes in the use of deuterium to chiral switch drugs that are a mixture of interconverting stereoisomers. This approach